ID

44240

Beschreibung

Efficacy and Safety of Aliskiren Administered in Combination With Amlodipine Versus Amlodipine Alone in African American Patients With Stage 2 Hypertension; ODM derived from: https://clinicaltrials.gov/show/NCT00853957

Link

https://clinicaltrials.gov/show/NCT00853957

Stichworte

Versionen (2)
  1. 02.05.18 02.05.18 -
  2. 20.09.21 20.09.21 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

20. September 2021

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Hypertension NCT00853957

Englisch

Eligibility Hypertension NCT00853957

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
men or women of african american background; self identified
Beschreibung

African American

Datentyp

boolean

Alias
UMLS CUI [1]
C0085756
patients with stage 2 hypertension defined as mssbp ≥ 160 mmhg and < 200 mmhg at visit 5 (randomization
Beschreibung

Hypertensive disease Stage | Sitting systolic blood pressure mean

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0020538
UMLS CUI [1,2]
C0699749
UMLS CUI [2,1]
C1319893
UMLS CUI [2,2]
C0444504
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
office blood pressure measured by cuff (msdbp ≥ 110 mmhg and/or mssbp ≥ 200 mmhg)
Beschreibung

Blood pressure measurement | Sitting diastolic blood pressure mean | Sitting systolic blood pressure mean

Datentyp

boolean

Alias
UMLS CUI [1]
C0005824
UMLS CUI [2,1]
C1319894
UMLS CUI [2,2]
C0444504
UMLS CUI [3,1]
C1319893
UMLS CUI [3,2]
C0444504
patients on 4 or more antihypertensive medications.
Beschreibung

Antihypertensive Agents Quantity

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0003364
UMLS CUI [1,2]
C1265611
patients with uncontrolled hypertension (mssbp >180 mmhg) taking more than 1 antihypertensive medication at visit 1
Beschreibung

Uncontrolled hypertension | Sitting systolic blood pressure mean | Antihypertensive Agents Quantity

Datentyp

boolean

Alias
UMLS CUI [1]
C1868885
UMLS CUI [2,1]
C1319893
UMLS CUI [2,2]
C0444504
UMLS CUI [3,1]
C0003364
UMLS CUI [3,2]
C1265611
refractory hypertension, defined as, unresponsive to triple drug therapy at the maximum dose of each drug, one of which must be a diuretic, and not at blood pressure goal (140/90 mmhg). therapy with a fixed dose combination of two active substances represent two drugs.
Beschreibung

Refractory hypertension | Pharmacotherapy Triple Unresponsive to Treatment | Pharmaceutical Preparations Maximum Tolerated Dose | Diuretics | Blood Pressure Goal failed | Combined Modality Therapy | Pharmaceutical Preparations Quantity Dose Stable

Datentyp

boolean

Alias
UMLS CUI [1]
C0860493
UMLS CUI [2,1]
C0013216
UMLS CUI [2,2]
C0205174
UMLS CUI [2,3]
C0205269
UMLS CUI [3,1]
C0013227
UMLS CUI [3,2]
C0752079
UMLS CUI [4]
C0012798
UMLS CUI [5,1]
C0005823
UMLS CUI [5,2]
C0679840
UMLS CUI [5,3]
C0231175
UMLS CUI [6]
C0009429
UMLS CUI [7,1]
C0013227
UMLS CUI [7,2]
C1265611
UMLS CUI [7,3]
C0178602
UMLS CUI [7,4]
C0205360
history of malignancy of any organ system (other than localized basal cell carcinoma of the skin), treated or untreated, within the past 5 years, regardless of whether there is evidence of local recurrence or metastases.
Beschreibung

Malignant Neoplasms Organ system Treated | Malignant Neoplasms Organ system Untreated | Exception Basal cell carcinoma Localized | Malignant Neoplasms Independent of Recurrent disease Local | Malignant Neoplasms Independent of Neoplasm Metastasis

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C0460002
UMLS CUI [1,3]
C1522326
UMLS CUI [2,1]
C0006826
UMLS CUI [2,2]
C0460002
UMLS CUI [2,3]
C0332155
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0007117
UMLS CUI [3,3]
C0392752
UMLS CUI [4,1]
C0006826
UMLS CUI [4,2]
C0332291
UMLS CUI [4,3]
C0277556
UMLS CUI [4,4]
C0205276
UMLS CUI [5,1]
C0006826
UMLS CUI [5,2]
C0332291
UMLS CUI [5,3]
C0027627
evidence of a secondary form of hypertension, including but not limited to any of the following:
Beschreibung

Secondary hypertension

Datentyp

boolean

Alias
UMLS CUI [1]
C0155616
coarctation of the aorta
Beschreibung

Aortic coarctation

Datentyp

boolean

Alias
UMLS CUI [1]
C0003492
hyperaldosteronism
Beschreibung

Hyperaldosteronism

Datentyp

boolean

Alias
UMLS CUI [1]
C0020428
unilateral or bilateral renal artery stenosis
Beschreibung

Unilateral renal artery stenosis | Bilateral renal artery stenosis

Datentyp

boolean

Alias
UMLS CUI [1]
C0856759
UMLS CUI [2]
C0856760
cushing's disease
Beschreibung

Cushing's disease

Datentyp

boolean

Alias
UMLS CUI [1]
C0221406
polycystic kidney disease
Beschreibung

Polycystic Kidney Disease

Datentyp

boolean

Alias
UMLS CUI [1]
C0022680
pheochromocytoma
Beschreibung

Pheochromocytoma

Datentyp

boolean

Alias
UMLS CUI [1]
C0031511
known keith-wagener grade iii or iv hypertensive retinopathy.
Beschreibung

Hypertensive Retinopathy Grade

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0152132
UMLS CUI [1,2]
C0441800
history of angioedema due to usage of an arb or ace inhibitor.
Beschreibung

Angioedema Due to Angiotensin II receptor antagonist | Angioedema due to angiotensin-converting-enzyme inhibitor

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0002994
UMLS CUI [1,2]
C0678226
UMLS CUI [1,3]
C0521942
UMLS CUI [2]
C1304495
history of hypertensive encephalopathy, cerebrovascular accident, transient ischemic attack, heart failure (nyha class ii-iv), coronary bypass graft surgery (cabg), percutaneous coronary intervention (pci), unstable angina pectoris, or myocardial infarction in the last 12 months
Beschreibung

Hypertensive Encephalopathy | Cerebrovascular accident | Transient Ischemic Attack | Heart failure New York Heart Association Classification | Coronary Artery Bypass Surgery | Percutaneous Coronary Intervention | Angina, Unstable | Myocardial Infarction

Datentyp

boolean

Alias
UMLS CUI [1]
C0151620
UMLS CUI [2]
C0038454
UMLS CUI [3]
C0007787
UMLS CUI [4,1]
C0018801
UMLS CUI [4,2]
C1275491
UMLS CUI [5]
C0010055
UMLS CUI [6]
C1532338
UMLS CUI [7]
C0002965
UMLS CUI [8]
C0027051
other protocol defined inclusion/exclusion criteria applied
Beschreibung

Eligibility Criteria Study Protocol

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1516637
UMLS CUI [1,2]
C2348563
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Hypertension NCT00853957

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
African American
Item
men or women of african american background; self identified
boolean
C0085756 (UMLS CUI [1])
Hypertensive disease Stage | Sitting systolic blood pressure mean
Item
patients with stage 2 hypertension defined as mssbp ≥ 160 mmhg and < 200 mmhg at visit 5 (randomization
boolean
C0020538 (UMLS CUI [1,1])
C0699749 (UMLS CUI [1,2])
C1319893 (UMLS CUI [2,1])
C0444504 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
Blood pressure measurement | Sitting diastolic blood pressure mean | Sitting systolic blood pressure mean
Item
office blood pressure measured by cuff (msdbp ≥ 110 mmhg and/or mssbp ≥ 200 mmhg)
boolean
C0005824 (UMLS CUI [1])
C1319894 (UMLS CUI [2,1])
C0444504 (UMLS CUI [2,2])
C1319893 (UMLS CUI [3,1])
C0444504 (UMLS CUI [3,2])
Antihypertensive Agents Quantity
Item
patients on 4 or more antihypertensive medications.
boolean
C0003364 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
Uncontrolled hypertension | Sitting systolic blood pressure mean | Antihypertensive Agents Quantity
Item
patients with uncontrolled hypertension (mssbp >180 mmhg) taking more than 1 antihypertensive medication at visit 1
boolean
C1868885 (UMLS CUI [1])
C1319893 (UMLS CUI [2,1])
C0444504 (UMLS CUI [2,2])
C0003364 (UMLS CUI [3,1])
C1265611 (UMLS CUI [3,2])
Refractory hypertension | Pharmacotherapy Triple Unresponsive to Treatment | Pharmaceutical Preparations Maximum Tolerated Dose | Diuretics | Blood Pressure Goal failed | Combined Modality Therapy | Pharmaceutical Preparations Quantity Dose Stable
Item
refractory hypertension, defined as, unresponsive to triple drug therapy at the maximum dose of each drug, one of which must be a diuretic, and not at blood pressure goal (140/90 mmhg). therapy with a fixed dose combination of two active substances represent two drugs.
boolean
C0860493 (UMLS CUI [1])
C0013216 (UMLS CUI [2,1])
C0205174 (UMLS CUI [2,2])
C0205269 (UMLS CUI [2,3])
C0013227 (UMLS CUI [3,1])
C0752079 (UMLS CUI [3,2])
C0012798 (UMLS CUI [4])
C0005823 (UMLS CUI [5,1])
C0679840 (UMLS CUI [5,2])
C0231175 (UMLS CUI [5,3])
C0009429 (UMLS CUI [6])
C0013227 (UMLS CUI [7,1])
C1265611 (UMLS CUI [7,2])
C0178602 (UMLS CUI [7,3])
C0205360 (UMLS CUI [7,4])
Malignant Neoplasms Organ system Treated | Malignant Neoplasms Organ system Untreated | Exception Basal cell carcinoma Localized | Malignant Neoplasms Independent of Recurrent disease Local | Malignant Neoplasms Independent of Neoplasm Metastasis
Item
history of malignancy of any organ system (other than localized basal cell carcinoma of the skin), treated or untreated, within the past 5 years, regardless of whether there is evidence of local recurrence or metastases.
boolean
C0006826 (UMLS CUI [1,1])
C0460002 (UMLS CUI [1,2])
C1522326 (UMLS CUI [1,3])
C0006826 (UMLS CUI [2,1])
C0460002 (UMLS CUI [2,2])
C0332155 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C0007117 (UMLS CUI [3,2])
C0392752 (UMLS CUI [3,3])
C0006826 (UMLS CUI [4,1])
C0332291 (UMLS CUI [4,2])
C0277556 (UMLS CUI [4,3])
C0205276 (UMLS CUI [4,4])
C0006826 (UMLS CUI [5,1])
C0332291 (UMLS CUI [5,2])
C0027627 (UMLS CUI [5,3])
Secondary hypertension
Item
evidence of a secondary form of hypertension, including but not limited to any of the following:
boolean
C0155616 (UMLS CUI [1])
Aortic coarctation
Item
coarctation of the aorta
boolean
C0003492 (UMLS CUI [1])
Hyperaldosteronism
Item
hyperaldosteronism
boolean
C0020428 (UMLS CUI [1])
Unilateral renal artery stenosis | Bilateral renal artery stenosis
Item
unilateral or bilateral renal artery stenosis
boolean
C0856759 (UMLS CUI [1])
C0856760 (UMLS CUI [2])
Cushing's disease
Item
cushing's disease
boolean
C0221406 (UMLS CUI [1])
Polycystic Kidney Disease
Item
polycystic kidney disease
boolean
C0022680 (UMLS CUI [1])
Pheochromocytoma
Item
pheochromocytoma
boolean
C0031511 (UMLS CUI [1])
Hypertensive Retinopathy Grade
Item
known keith-wagener grade iii or iv hypertensive retinopathy.
boolean
C0152132 (UMLS CUI [1,1])
C0441800 (UMLS CUI [1,2])
Angioedema Due to Angiotensin II receptor antagonist | Angioedema due to angiotensin-converting-enzyme inhibitor
Item
history of angioedema due to usage of an arb or ace inhibitor.
boolean
C0002994 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C0521942 (UMLS CUI [1,3])
C1304495 (UMLS CUI [2])
Hypertensive Encephalopathy | Cerebrovascular accident | Transient Ischemic Attack | Heart failure New York Heart Association Classification | Coronary Artery Bypass Surgery | Percutaneous Coronary Intervention | Angina, Unstable | Myocardial Infarction
Item
history of hypertensive encephalopathy, cerebrovascular accident, transient ischemic attack, heart failure (nyha class ii-iv), coronary bypass graft surgery (cabg), percutaneous coronary intervention (pci), unstable angina pectoris, or myocardial infarction in the last 12 months
boolean
C0151620 (UMLS CUI [1])
C0038454 (UMLS CUI [2])
C0007787 (UMLS CUI [3])
C0018801 (UMLS CUI [4,1])
C1275491 (UMLS CUI [4,2])
C0010055 (UMLS CUI [5])
C1532338 (UMLS CUI [6])
C0002965 (UMLS CUI [7])
C0027051 (UMLS CUI [8])
Eligibility Criteria Study Protocol
Item
other protocol defined inclusion/exclusion criteria applied
boolean
C1516637 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video